Downloaded from: justpaste.it/Igenex
Igenex introduces a cost-effective Lyme disease test in 2020 Lyme disease or other tick-borne diseases generally requires a huge sum of money for its test, treatment, and other miscellaneous medical activities associated with the disease. A recent survey made by Igenex has found that almost 36 percent of patients with Lyme and other tick-borne disease spent more than $10’000 on an average. Igenex is a leading tick-borne disease testing lab based in California, which has currently introduced the Ab (BCA) assays for both Lyme disease and tick-borne relapsing fever. It is a cost-effective test for Lyme disease and offers a simple positive or a negative result to reveal the exposure to Borreliae. Although Igenex has other immunoblot tests like IgM and IgG that offers the great standard in Lyme and TBRF testing, due to its high cost, some patients cannot afford it. Hence Igenex has introduced the affordable BCA assays test to help maximum patients get the best quality testing at an affordable rate. The president and laboratory director of Igenex has recently announced the reason for introducing the budgetfriendly testing, which is because the spread of Lyme and TBRF is increasing day by day, and the sick patients coming from different economic background needs an accurate diagnosis to start with an appropriate diagnosis. The costing for each BCA assay or TBRF is $195. Which you can order through a physician. Let’s get a look at the advantages of Ab Assays both for TBRF and Lyme disease. It offers a simple, easy to understand and most importantly cost-effective positive or negative result. It successfully detects antibodies for Borrelia species or strains from countries like Europe, Australia, and north-America. The test can detect both IgM and IgG antibodies. The testing is better when compared to two-tier ELISA.
It is recently announced by the CDC that Lyme disease is more common than thought previously. The number of cases diagnosed each year in the US ranges to over 400,000. Hence making the disease one of the most common diseases in the country and four times more common than tuberculosis, syphilis, and HIV/AIDS combined. A recent survey made by a leading testing lab in California Igenex, of patients with the tick-borne disease, has analyzed a total of 198 patient cases ranging from the year 2018 and 2019 to those who were tested by Igenex. The points that researchers have sought to determine are like, the time that is taken by patients to obtain a proper diagnosis, the number of doctors visited by them, the IGENEX - Lyme disease testing cost incurred by them ultimately. The result revealed by the survey is: More than three years is needed by 45% of patients to obtain a proper and accurate diagnosis More than ten doctors are being consulted by 24% of patients before getting a proper diagnosis
The number of patients suffering from long term side effects for not getting diagnosed sooner ranges to 86% The numbers of patients who have to either quit their jobs or cut back the working hours due to their symptoms ranges to 65% The bottom line The above details give you an idea about how the Lyme disease has taken a toll on the life of a common man in the US. Thus, making the diagnosis of the disease quite necessary for individuals coming from all sorts of economic background. Thus, to meet the growing needs of people, a leading tick-borne disease testing lab based in California Igenex introduces a cost-effective test for Lyme disease and TBRF.